NDC 83301-0010-03 - Metformin Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 83301-0010
- Requested NDC
- 83301-0010-03
- Package NDCs from labels
- 83301-0010-1, 83301-0010-2, 83301-0010-3, 83301-0010-03
- Manufacturer
- Mullan Pharmaceutical Inc. | CSPC Ouyi Pharmaceutical Co., Ltd.
- Effective date
- 2025-10-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Metformin Hydrochloride | Mullan Pharmaceutical Inc. | CSPC Ouyi Pharmaceutical Co., Ltd. | 2025-10-28 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83301-0010-1 | Metformin Hydrochloride | 100 in 1 BOTTLE | TABLET, COATED | 100 | 6 | |
| 83301-0010-2 | Metformin Hydrochloride | 500 in 1 BOTTLE | TABLET, COATED | 500 | 6 | |
| 83301-0010-3 | Metformin Hydrochloride | 1000 in 1 BOTTLE | TABLET, COATED | 1000 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 83301-0010 | METFORMIN HYDROCHLORIDE TABLET, COATED [MULLAN PHARMACEUTICAL INC.] | 4 | Current NDC, 3 package rows | 20240324_082b4de9-e452-fe71-e063-6394a90ac863.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 83301-0010-1 | EA - Each | 83301-0010 | 16a38516-a7c6-4f11-a655-118b462e675b | 1 | 2025-07-08 |
| 83301-0010-2 | EA - Each | 83301-0010 | 307aab11-49de-46b6-830e-891e28249164 | 1 | 2025-07-08 |
| 83301-0010-3 | EA - Each | 83301-0010 | 42878dc7-95f7-406b-9955-4ba3dccd61e3 | 1 | 2025-07-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Precision Dose, Inc. | 37ff1b8e-a434-41c0-82e1-4583842921a5 | 2025-12-02 | Boxed warning, Warnings, Adverse reactions | ANDA205096 861007 861010 861004 786Z46389E |
| Sitagliptin and Metformin hydrochloride | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | Par Health USA, LLC | 43e3b1c9-3cbd-8dc3-e063-6394a90a10a2 | 2025-11-30 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin HCl | METFORMIN HCL | A-S Medication Solutions | d43ccbc3-eb0b-400e-a6fa-31202dec3a71 | 2025-11-10 | Warnings, Adverse reactions | 861004 786Z46389E |
| Metformin HCl | METFORMIN HCL | A-S Medication Solutions | 21cbb326-9dee-40ec-ac25-0dad79e3302b | 2025-11-07 | Warnings, Adverse reactions | 861004 786Z46389E |
| Metformin HCl | METFORMIN HCL | A-S Medication Solutions | 397c2bf4-35be-4e75-b5a6-426e3fa09548 | 2025-11-06 | Warnings, Adverse reactions | 861004 786Z46389E |
| Metformin HCl | METFORMIN HCL | PD-Rx Pharmaceuticals, Inc. | 235680e6-1c3e-45b8-902e-866583f1aef3 | 2025-11-04 | Warnings, Adverse reactions | 861004 786Z46389E |
| Metformin hydrochloride ER | METFORMIN HYDROCHLORIDE | AvKARE | 1aa40000-877f-8ea4-e063-6394a90a0e31 | 2025-11-04 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Linagliptin and metformin hydrochloride | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | Novadoz Pharmaceuticals LLC | 5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb | 2025-11-04 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Mullan Pharmaceutical Inc. | 082b4de9-e452-fe71-e063-6394a90ac863 | 2025-10-28 | Boxed warning, Warnings, Adverse reactions | ANDA205096 83301-0008-1 83301-0010-3 83301-0009-3 83301-0009-2 83301-0010-1 83301-0008-2 83301-0010-2 83301-0009-1 83301-0008-3 83301-0008 83301-0009 83301-0010 83301001003 861007 861010 861004 423f5f82-8524-65aa-e063-6294a90a1180 082b4de9-e452-fe71-e063-6394a90ac863 786Z46389E |
| LACRIFRESH HYDRAPF | GLYCERIN, POVIDONE | AVIZOR, S.A. | 41bbd23e-0ec8-eb18-e063-6294a90a46d1 | 2025-10-27 | Warnings | FZ989GH94E |
| LACRIFRESH HYDRAMAXPF | GLYCERIN, POVIDONE | AVIZOR, S.A. | 41be1604-89b4-7ec3-e063-6294a90a3331 | 2025-10-27 | Warnings | FZ989GH94E |
| Stye | POLYVINYL ALCOHOL AND POVIDONE | Medtech Products Inc. | 60c11d3d-df20-4d1c-b425-49a84fecea30 | 2025-10-23 | Warnings | FZ989GH94E |
| iVIZIA Dry Eye | POVIDONE | Thea Pharma Inc. | 1ef73cb1-da48-a713-e063-6294a90afa9d | 2025-10-20 | Warnings | FZ989GH94E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 0230a3c3-34cf-478b-88c3-4d96e5300018 | 2025-10-15 | Boxed warning, Warnings, Adverse reactions | 861007 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | c72cfd1a-dce9-43a3-88e2-3cf1d9078b52 | 2025-10-15 | Boxed warning, Warnings, Adverse reactions | 861004 786Z46389E |
| Glipizide and Metformin Hydrochloride | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | AvKARE | 13be49d2-0ce9-a78a-e557-ded85ddc808f | 2025-10-14 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 403349a1-ec19-8982-e063-6294a90aa060 | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | 861007 786Z46389E |
| Metformin hydrochloride | METFORMIN HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 4be72741-4f6d-6689-e054-00144ff8d46c | 2025-09-22 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Coupler LLC | 3eeee3b7-188a-05a0-e063-6294a90a1853 | 2025-09-16 | Boxed warning, Warnings, Adverse reactions | 861007 786Z46389E |
| Metformin | METFORMIN | Coupler LLC | 3edc9b51-ddee-61f8-e063-6294a90ad3c5 | 2025-09-15 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.